Wolverine Asset Management LLC Sarepta Therapeutics, Inc. Put Options Transaction History

Wolverine Asset Management LLC

$4.35 Billion
Q3 2024

Put Options

18 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 13, 2024	SELL	$93.7 - $141.53 $10 Million - $15.1 Million	-106,900 Reduced 80.86%	25,300 $3.28 Million
Q4 2023 Feb 01, 2024	BUY	$67.31 - $124.76 $13,462 - $24,952	200 Added 0.15%	132,200 $12.7 Million
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $13.5 Million - $16.3 Million	131,900 Added 131900.0%	132,000 $16 Million
Q2 2023 Aug 07, 2023	BUY	$106.4 - $157.19 $10,640 - $15,719	100 New	100 $11,000
Q2 2022 Aug 03, 2022	SELL	$62.69 - $88.44 $6.27 Million - $8.84 Million	-100,000 Reduced 46.13%	116,800 $8.76 Million
Q1 2022 May 04, 2022	SELL	$63.15 - $90.42 $1.86 Million - $2.66 Million	-29,400 Reduced 11.94%	216,800 $16.9 Million
Q4 2021 Feb 09, 2022	BUY	$77.28 - $99.42 $1.61 Million - $2.07 Million	20,800 Added 9.23%	246,200 $22.2 Million
Q3 2021 Nov 12, 2021	BUY	$65.97 - $92.48 $7.45 Million - $10.5 Million	113,000 Added 100.53%	225,400 $20.8 Million
Q2 2021 Aug 13, 2021	BUY	$69.38 - $86.75 $7.42 Million - $9.27 Million	106,900 Added 1943.64%	112,400 $8.74 Million
Q1 2021 May 13, 2021	SELL	$72.25 - $168.95 $1.02 Million - $2.38 Million	-14,100 Reduced 71.94%	5,500 $409,000
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $401,792 - $571,968	3,200 Added 19.51%	19,600 $3.34 Million
Q3 2020 Nov 13, 2020	BUY	$127.12 - $172.34 $177,968 - $241,276	1,400 Added 9.33%	16,400 $2.3 Million
Q1 2020 May 13, 2020	SELL	$82.38 - $131.64 $1.09 Million - $1.74 Million	-13,200 Reduced 46.81%	15,000 $1.47 Million
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $336,732 - $596,552	-4,400 Reduced 13.5%	28,200 $3.64 Million
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $1.06 Million - $2.28 Million	14,500 Added 80.11%	32,600 $2.46 Million
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $1.54 Million - $2.08 Million	13,700 Added 311.36%	18,100 $2.75 Million
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $138,671 - $197,184	1,300 Added 41.94%	4,400 $524,000
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $222,393 - $476,439	3,100 New	3,100 $409,000

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.23 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.07 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$745 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$519 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$508 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.

Account